Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

onditions and shares or other potentially dilutive securities not otherwise contemplated in the share denominator utilized in the applicable year's financial outlook range) are fully dilutive and outstanding shares from their date of grant or issuance.

To properly evaluate Emdeon's business, Emdeon encourages investors to review the GAAP financial information included in this release, and not rely on any single financial measure to evaluate Emdeon's business.  Emdeon also strongly encourages investors to review the reconciliation of GAAP net income and GAAP net income per diluted share to the applicable non-GAAP measures of Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income per fully diluted share.  These non-GAAP measures, as Emdeon defines them, may not be similar to non-GAAP measures used by other companies.

Management uses Adjusted EBITDA and Adjusted Net Income per fully diluted share to facilitate a comparison of Emdeon's operating performance on a consistent basis from period to period that, when viewed in combination with Emdeon's GAAP results, management believes provides a more complete understanding of factors and trends affecting Emdeon's business than GAAP measures alone. Management believes these non-GAAP measures assist Emdeon's board of directors, management, lenders and investors in comparing Emdeon's operating performance on a consistent basis because they remove where applicable, the impact of Emdeon's capital structure, asset base, acquisition accounting, non-cash charges and non-operating items from Emdeon's operations.

Emdeon Inc.Reconciliation of GAAP Net Income to Adjusted EBITDA(unaudited and amounts in thousands)For the Three MonthsFor the Nine Months Ended September 30, Ended September 30, 2011201020112010Net income $
,273$
,627$
22,777$
8,141Interest expense, net12,57316,15937,84847,735Income tax provision8,6017,49821,69627,650Depreciation and amortization39,83030,001116,78687,054EB
'/>"/>

SOURCE Emdeon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... will be participating in the Goldman Sachs 2015 European ... in London on Thursday, September ... 1927 and headquartered in Warsaw, Indiana ... healthcare.  We design, manufacture and market orthopaedic reconstructive products; ...
(Date:8/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and ... development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical ... from the Japan PMDA for the manufacture ... commercial drug in July. STA is now ...
(Date:8/27/2015)... , Aug. 27, 2015  Symbiomix today announced ... clinical study, the second pivotal trial of SYM-1219, which ... of bacterial vaginosis (BV). Earlier this year Symbiomix announced ... Symbiomix expects to finish this second pivotal trial by ... Drug Application (NDA) filing with the U.S. Food and ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4
... Texas, July 21, 2011 Assured Pharmacy, Inc. (Other ... medications to more than 3,000 sufferers of chronic pain, ... Pink Current Information with the OTC Markets, using the ... have been posted on the OTC Markets website and ...
... N.J., July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... financial results for the second quarter 2011 prior to the ... John H. Johnson, Chief Executive Officer and President, ... will host an investment community conference call beginning at 9:00 ...
Cached Medicine Technology:Assured Pharmacy Upgrades to OTC Pink Current Information 2Assured Pharmacy Upgrades to OTC Pink Current Information 3Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011 2
(Date:8/27/2015)... ... August 27, 2015 , ... ... for quantitative PCR (qPCR) in the last decade. New features such ... operating costs. On the flipside, where do lab managers, technicians, and researchers find ...
(Date:8/27/2015)... ... ... According to an article published August 19 on Healio, The ... doctors and patients on the best practices for type 2 diabetes care. The article ... new version is taking into account nearly a decade of recent research data. While ...
(Date:8/27/2015)... ... August 27, 2015 , ... Thriveology Founders, Dr. Carly Letzt ... at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, 2015 at ... featured in media outlets as health authorities, and will present a two part seminar ...
(Date:8/27/2015)... ... August 27, 2015 , ... In mid-May, ... marijuana industry with the launch of its Doobster platform, a HIPAA-compliant mobile application ... products from their smart phones and tablets. Well, Doobster, “The App That ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 ... $100 billion, according to a Georgia State University study. , While most people ...
Breaking Medicine News(10 mins):Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2
... ... ), offers men and women a more youthful look for summer with BOTOX Cosmetic and the ... ... Regenass, and her staff understand just how frustrating the signs of aging and sun damage can ...
... Scholarship Program (HPSP) Supports Students Pursuing Medical Careers with ... June 22 The U.S. Army Medical Department announced ... its Health Professions Scholarship Program (HPSP) to $1,992 per ... many medical and dental students are faced with anxiety ...
... - Bioniche Life Sciences Inc. ("Bioniche"; TSX: BNC), ... an update on its corporate activities. , In ... delays in concluding a partnering transaction related to ... Urocidin(TM), for the intravesical treatment of non-muscle-invasive bladder ...
... self-help technique called guided imagery has been steadily gaining ... insurance companies, as new research demonstrates its efficacy for ... June 22 A new self-help audio recording designed ... or other viral and bacterial illnesses was released this ...
... ... latex clear and color condoms, IBI Synergy, Inc. is looking for organizations/individuals that are interested in ... 1,000 condoms with the minimum donation being two cases. , ... Fremont, Calif. (PRWEB) June 21, 2009 -- Are you looking for a few ...
... , ... the release of a comprehensive global report on Brachytherapy market. Brachytherapy is emerging as ... billion by 2015. Primary growth drivers include rising prevalence of cancer, growing medical awareness, ... ...
Cached Medicine News:Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 2Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 3Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 4Health News:U.S. Army Increases Medical and Dental School Benefits 2Health News:U.S. Army Increases Medical and Dental School Benefits 3Health News:Bioniche Provides a Corporate Update 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 3Health News:Premium Latex Condom Donation by IBI Synergy, Inc. Are You Looking For a Few Good Latex Condoms? 2Health News:Premium Latex Condom Donation by IBI Synergy, Inc. Are You Looking For a Few Good Latex Condoms? 3Health News:US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Health News:US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3
... latest addition to the HemoCue glucose product range. ... combines the precision and accuracy of a laboratory ... ease of use. The new pocket size analyser ... date and time for up to 600 measurements. ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... should not suffice, then electronic magnification comes into ... set today. With an electronic television reader, text, ... 70 times. A video camera shows a recorded ... monitor. The television reader has been especially developed ...
... combination of topography, auto-refraction and keratometer in ... devices. The compactness of this instrument is ... space and cost saving solution. Highly ... time and easy handling makes working with ...
Medicine Products: